Want to join the conversation?
$PFE 2Q15 Q&A: Rubin of Goldman Sachs asked whether the company considers putting its Consumer business up for sale. Ian answered that Nexium OTC has been an incredible success and the company continues to invest in the Consumer business. At this moment, the Consumer business is a very valuable and growing asset for Pfizer, added Ian.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.